Idiopathic inflammatory myopathies
IE Lundberg, M Fujimoto, J Vencovsky… - Nature Reviews …, 2021 - nature.com
Idiopathic inflammatory myopathies (IIM), also known as myositis, are a heterogeneous
group of autoimmune disorders with varying clinical manifestations, treatment responses …
group of autoimmune disorders with varying clinical manifestations, treatment responses …
Classification and management of adult inflammatory myopathies
A Selva-O'Callaghan, I Pinal-Fernandez… - The Lancet …, 2018 - thelancet.com
Inflammatory myopathies, collectively known as myositis, are heterogeneous disorders
characterised by muscle inflammation, and frequently accompanied by extramuscular …
characterised by muscle inflammation, and frequently accompanied by extramuscular …
Emerging topical and systemic JAK inhibitors in dermatology
F Solimani, K Meier, K Ghoreschi - Frontiers in immunology, 2019 - frontiersin.org
Accumulating data on cellular and molecular pathways help to develop novel therapeutic
strategies in skin inflammation and autoimmunity. Examples are psoriasis and atopic …
strategies in skin inflammation and autoimmunity. Examples are psoriasis and atopic …
Inflammatory muscle diseases
MC Dalakas - New England Journal of Medicine, 2015 - Mass Medical Soc
Inflammatory Muscle Diseases | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
Detection of interferon alpha protein reveals differential levels and cellular sources in disease
Type I interferons (IFNs) are essential mediators of antiviral responses. These cytokines
have been implicated in the pathogenesis of autoimmunity, most notably systemic lupus …
have been implicated in the pathogenesis of autoimmunity, most notably systemic lupus …
Study of tofacitinib in refractory dermatomyositis: an open‐label pilot study of ten patients
Objective This open‐label 12‐week study was conducted to evaluate the efficacy and safety
of tofacitinib, a JAK inhibitor, in treatment‐refractory active dermatomyositis (DM). Methods …
of tofacitinib, a JAK inhibitor, in treatment‐refractory active dermatomyositis (DM). Methods …
239th ENMC international workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018
Idiopathic inflammatory myopathies (IIM) are a heterogenous family of diseases that can
affect the muscles, skin, lungs, and joints. There have been prior attempts to classify IIMs …
affect the muscles, skin, lungs, and joints. There have been prior attempts to classify IIMs …
Immunopathogenic mechanisms of systemic autoimmune disease
M Wahren-Herlenius, T Dörner - The Lancet, 2013 - thelancet.com
Systemic lupus erythematosus, Sjögren's syndrome, and dermatomyositis are systemic
autoimmune diseases that develop after environmental triggering of genetically susceptible …
autoimmune diseases that develop after environmental triggering of genetically susceptible …
Use of JAK inhibitors in dermatomyositis: a systematic literature review
JJ Paik, G Lubin, A Gromatzky… - Clinical and …, 2022 - pmc.ncbi.nlm.nih.gov
Dermatomyositis (DM) is an idiopathic inflammatory myopathy that commonly manifests with
proximal muscle weakness and is associated with extramuscular pathology including …
proximal muscle weakness and is associated with extramuscular pathology including …
Inflammation induced loss of skeletal muscle
P Londhe, DC Guttridge - Bone, 2015 - Elsevier
Inflammation is an important contributor to the pathology of diseases implicated in skeletal
muscle dysfunction. A number of diseases and disorders including inflammatory myopathies …
muscle dysfunction. A number of diseases and disorders including inflammatory myopathies …